Also known as Emblon, Fentamox, Nolvadex-D, Oestrifen, Tamofen, Nolvadex, Noltam, and Soltamox
Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting.
Source: WikipediaEstimated Total Cost: $17.22 for an average of 28 days supply
Patients are most commonly prescribed tamoxifen to treat breast cancer, mastectomy, metastatic cancer, and hot flashes.
Critical Interactions
Significant Interactions
Patients taking tamoxifen most commonly experience side effects like hot flashes, absence of menstruation, and flushing.